Strides Pharma Science Limited (BOM:532531)
India
· Delayed Price · Currency is INR 887.45
+17.35 (1.99%)
At close: Jul 11, 2025
Strides Pharma Science Employees
Strides Pharma Science had 3,065 employees as of March 31, 2024. The number of employees increased by 215 or 7.54% compared to the previous year.
Employees
3,065
Change (1Y)
215
Growth (1Y)
7.54%
Revenue / Employee
14.90M INR
Profits / Employee
11.72M INR
Market Cap
81.82B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 3,065 | 215 | 7.54% |
| Mar 31, 2023 | 2,850 | 203 | 7.67% |
| Mar 31, 2022 | 2,647 | 257 | 10.75% |
| Mar 31, 2021 | 2,390 | -579 | -19.50% |
| Mar 31, 2020 | 2,969 | 933 | 45.83% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Reliance Industries | 347,362 |
| HDFC Bank | 214,521 |
| Tata Consultancy Services | 607,979 |
| Bharti Airtel | 28,673 |
| ICICI Bank | 187,765 |
| State Bank of India | 236,226 |
| Infosys | 323,578 |
| Hindustan Unilever | 18,802 |
Strides Pharma Science News
- 2 months ago - Strides Pharma receives USFDA approval for Celecoxib Capsules - Business Upturn
- 3 months ago - Strides Pharma incorporates new subsidiary ‘Pivot Path’ to boost life sciences and digital innovation - Business Upturn
- 5 months ago - Strides Pharma shares surge 5% as revenue jumps 15% YoY in Q3 FY25 - Business Upturn
- 5 months ago - Strides Pharma Q3 FY25 Results: Revenue up 15% YoY to Rs 1,154 crore, Net Profit up 60% YoY - Business Upturn
- 6 months ago - Strides Pharma receives USFDA approval for acetaminophen and ibuprofen tablets, expanding OTC portfolio - Business Upturn